Patrick Hurteloup
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 28
- Cancer Treatment and Pharmacology 17
- Neutropenia and Cancer Infections 8
- Hematology 11
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 5
- Co-authors
- Philippe J. M. Chollet (3 shared papers)Henri Hubert Roche (3 shared papers)Jean Pierre Olivier (2 shared papers)B Chevallier (5 shared papers)R Cebolla Rosell (2 shared papers)Marc-André Mahé (1 shared paper)Marcello Riggi (2 shared papers)Jean‐Yves Douillard (2 shared papers)
In The Last Decade
Patrick Hurteloup
39 papers receiving 3.4k citations
Patrick Hurteloup's Hit Papers
Peers
Comparison fields: 5 of 82
- Hematology 561
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 425
- Surgery 584
Countries citing papers authored by Patrick Hurteloup
This map shows the geographic impact of Patrick Hurteloup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hurteloup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hurteloup more than expected).
Fields of papers citing papers by Patrick Hurteloup
This network shows the impact of papers produced by Patrick Hurteloup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hurteloup. The network helps show where Patrick Hurteloup may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Hurteloup, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Hit paper breakdown → | 2006 | 1270 |
| 2 | Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Hit paper breakdown → | 2009 | 611 |
| 3 | 2008 | 286 | |
| 4 | 1997 | 269 | |
| 5 | Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. | 1993 | 225 |
| 6 | 1993 | 197 | |
| 7 | 1998 | 128 | |
| 8 | Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer. | 1985 | 83 |
| 9 | A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75. | 1996 | 71 |
| 10 | 1989 | 56 | |
| 11 | 1992 | 46 | |
| 12 | 1989 | 36 | |
| 13 | Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. | 1995 | 33 |
| 14 | Phase II clinical evaluation of 4'-epi-doxorubicin. | 1983 | 30 |
| 15 | 1990 | 20 | |
| 16 | 1993 | 17 | |
| 17 | Pharmacokinetics of idarubicin after oral administration in elderly leukemic patients. | 1990 | 16 |
| 18 | 1987 | 15 | |
| 19 | Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin. | 1986 | 14 |
| 20 | 1984 | 14 |
About Patrick Hurteloup
Patrick Hurteloup is a scholar working on Oncology, Hematology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Acute Myeloid Leukemia Research (11 papers), Breast Cancer Treatment Studies (9 papers), Neutropenia and Cancer Infections (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Hematology (561 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (425 citations) and Surgery (584 citations). Patrick Hurteloup has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Philippe J. M. Chollet, Henri Hubert Roche, Jean Pierre Olivier, B Chevallier, R Cebolla Rosell, Marc-André Mahé, Marcello Riggi, Jean‐Yves Douillard, Mario De Lena and Bernard Chevallier. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Blood, British Journal of Haematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.